1You can download the available power points by clicking on the name of the speakers in red.



07:30 – 09:00: Registration

09:00 – 12:00: IHN General Assembly

09:00 – 12:00: Education/training morning in French (open to all participants)
Certified “Développement Profesionnel des Connaissances“
Chairs: Rachid Djoudi and Nadia Oubouzar

(09:00 – 10:30)
– French national health authority recommendations for RBC and platelet transfusion: the “hot” topics. Mauricette Michallet and André Lienhart (France)

–  Plasma transfusion: best practice. Yves Ozier (France)

(10:30 – 11:00) Coffee Break

(11:00 – 11:30) Dry plasma: just for the battlefield? Anne Sailliol (France)
(11:30 – 12:00) Good bye TRALI, Good morning TACO. From pathophysiology to prevention. Philippe Renaudier (France) on behalf of the CNCRH

12:15 – 13:45: Lunch symposium organised by Macopharma
Chairs: Constantina Politis, Greece, and Jean-Pierre Allain, United Kingdom

– International, prospective, CRO-managed haemovigilance study on methylene blue-treated plasma. Ignacio Alvarez (Macopharma)
– Assessment of safety when methylene blue and quarantine plasma are used interchangeably. Walter Nussbaumer (Austria)

14:00 – 18:15: Opening Session: Twenty years of haemovigilance: what are the achievements, and where to from here?
Chairs: Erica Wood and Pierre Tiberghien

(14:00-14:55) Welcome and Opening. Erica Wood, President IHN and representatives of French health authorities and supporting organisations
(14-55-15:25) Haemovigilance in Europe: What do health authorities expect from haemovigilance? Deirdre Fehily (European Commission)
(15:25-16:20) Haemovigilance lessons and perspectives from around the world. Representatives from international haemovigilance systems, including Bernard Lassale (France), Brazil: Auristela Maciel Lins (Brazil), Steven Anderson (USA) and Dr Bisht (India)

(16:20-16:50) Coffee Break (Poster viewing and expo visits)

(16:50-17:20) How do we evaluate cost-effectiveness in transfusion and haemovigilance? Mart Janssen (The Netherlands)
(17:20-17:50) Haemovigilance: are we asking the right questions, and collecting and analysing the right information? Tjerk van der Schaaf( (The Netherlands)
(17:50-18:15) Panel discussion with audience participation

18:15 – 19:15: Welcome Reception on the exhibition floor


08:30 10:10: Plenary Session: Inflammation and its implications for blood donors and transfused patients
Chairs: Olivier Garraud and Martin Schipperus

 (08:30-09:00) Introduction to post-transfusion inflammation and the potential role of biological response modifiers. Olivier Garraud (France )
What can “Omics” bring to transfusion medicine? Michel Prudent (Switzerland)
(09:30-10:00) TRALI : an update on risk factors, prevention and treatment. Alexander Vlaar (The Netherlands)

(10:00 – 10:30) Coffee Break (Poster viewing and expo visits)

10:30 – 11:45: Plenary Session: Sickle cell disease and hyperhaemolysis
Chairs: France Pirenne and Paula Bolton-Maggs

(10:30-11:00) Epidemiology, risk factors and new therapeutic approaches in France. France Pirenne (France)
(11:00-11:30) How do I treat DHTR?  Jo Howard (United Kingdom)
(11:30-11:45) Delayed hyperhemolysis transfusion reaction: An under-reported reaction in France. Claire Rieux (France)

11:45 – 13:15: Lunch symposium organized by Grifols: DO YOU HAVE THE FULL PICTURE OF YOUR TRANSFUSION PROCESS?

(11:50-12:00) Welcome and introduction
(12:00-12:30) Barcoding and computerization in improving the safety of transfusion. Jonathan Kay, United Kingdom
Barcode technology for transfusion safety: the experience of Servizio di Immunoematologia e Medicina Trasfusionale di Biella. Gennaro. Mascaro, Italy

13:15 – 13:45 Poster viewing (poster presenters to be in attendance at their posters) and expo visits

13:45 – 15:30: Plenary Session: Haemovigilance in Africa
Chairs: Jean-Pierre Allain and Jean-Claude Faber

(13:45-14:35) Donor and recipient vigilance in two key clinical trials in Africa
– Emergency evaluation of convalescent plasma for Ebola viral disease in Guinea. Nyankove Yves Haba (Guinea)
AIMS Trial (Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transmitted Malaria). Alex Owusu-Ofori (Ghana)
 (14:35-15:30) Participating country presentations from Africa
   * Neo Moleli (South Africa)
   * Salam Sawadogo (Burkina Faso)
   * Michael Acquah (Ghana)
   * Abiyi Belay Ambaye (Ethiopia)

(15:30 – 16:00) Coffee Break (Poster viewing and expo visits)

16:00 – 18:30: Parallel Sessions
1) Tools for practice improvement
Chairs: Jean-Jacques Cabaud and Kevin Land
(16:00-16:40) Simulation as a tool for training. Antoine Tesniere and Alexandre Mignon (France)
(16:40-18:10) 6 Short presentations from selected abstracts:

– Horizon scanning through media mining to identify medical products of human origin-associated infectious risks: preliminary result of a pilot NOTIFY project study. Evangelina Petrisli (Italy/NOTIFY)
– Transfusion-related acute lung injury (TRALI) occurrence among female Medicaid beneficiaries of childbearing age, as recorded in large administrative databases in the US, during 2007-2010.  Mikhail Menis (USA)
– Incidence of plasma transfusion reactions and variance thereof – an analysis of 7 years of ISTARE data. (Nicholas Saadah, Netherlands/ISTARE)
– Duration of platelet storage and outcome of critically ill patients: results from analysis of Australian intensive care registry data. Cécile Aubron (France/Australia)
– Laboratory surveys from UK Transfusion Laboratory Collaborative (UKTLC) confirm cause for concern. Joanne Bark (United Kingdom)
– Donor safety in haemapheresis: implementation of the IHN Standard 2014 into the online system for assessment and evaluation of donor and apheresis complications. Hans-Gert Heuft (Germany)

(18:10-18:30) Panel discussion with audience  participation: Data and education to improve practice

2) Microbiological haemovigilance
Chairs: Syria Laperche and Lorna Williamson
(16:00-17:00)  Hepatitis E – to screen or not to screen? Lorna Williamson (United Kingdom) and Hans Zaaijer (The Netherlands)
(17:00-17:30) Look-back studies to assess microbiological risks. Syria Laperche (France)
(17:30-18:00) Changes in deferrals for MSM: implications for haemovigilance. Josiane Pillonel (France)
(18:00-18:30) Panel discussion with audience participation


Evening:  Participant Diner in the Musée du Vin


FRIDAY, MARCH 11, 2016

08:30 – 10:00: Parallel Sessions

1) Donor haemovigilance – Preventing and managing adverse reactions in donors
Chairs: Jo Wiersum and Xavier Tinard
(08:30-08:55) Detection and prevention of vasovagal reactions in blood donors. Mindy Goldman (Canada)
(08:55-09:10)- A prospective randomised study to reduce vasovagal reactions: the EVASION study results. Pierre Tiberghien (France)
(09:10-09:35) Young donors: assessing the risks. Peter Tomasulo (USA)

(09:35-10:05) 2 Short presentations from selected abstracts:

– Drinking water before whole blood donation does not reduce the incidence of vasovagal reactions in high-risk donors. Pairaya Rujirojindakul (Thailand)
– How to reduce delayed donor adverse reactions? Nuria Nomen Calvet (Spain)

2) Recipient haemovigilance
Chairs: Gerald Daurat and Hasan Abbas Zaheer
(08:30-09:00) Human factors and transfusion errors. Paula Bolton-Maggs (United Kingdom)
(09:00-09:30) Transfusion in crisis situations. Celine Roche and Patrick Jault (France)
(09:30-10:00) 2 Short presentations from selected abstracts

– Might TACO be the most critical safety concern? Education for junior doctors to improve TACO awareness and management. Gerald Daurat (France)
– Fatal adverse reactions associated with transfusion of blood components reported to ISTARE, 2006-2013. Constantina Politis (Greece/ISTARE)

(10:00 – 10:30) Coffee Break (Poster viewing and expo visits)

10:30 – 12:30: Plenary Session: Iron – not enough, or too much!
Chairs: Peter Tomasulo and Philippe Renaudier
(10:30-10:55) Current concepts in iron metabolism relevant to transfusion and haemovigilance. Pierre Brissot (France)

(10:55-11:20) Iron deficiency in donors: how to assess and prevent it? Kevin Land (USA)
(11:20-11:45) Hereditary haemochromatosis: implications for donors, products and patients. Gilles Follea (France)

(11:45-12:15) Transfusional iron overload. Joan Cid (Spain)
(12:15-12:35) A haemovigilance view of transfusion iron overload. Philippe Renaudier (France)

12:30 – 13:30: Awards and Closing Session
(12:35-12:45) Presentation of IHN Medal and Award. Erica Wood, IHN President, and awardees
(12:45-13:30) Invited Lecture (IHN Award winner lecture)


14:30 – 16:30: Open session for informal discussions on haemovigilance research ideas